Biomerica (BMRA) Operating Expenses (2010 - 2026)

Biomerica has disclosed Operating Expenses across 17 years of filings, most recently posting $1.3 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $1.3 million, up 2.03% year-over-year; the trailing twelve-month figure through Feb 2026 was $5.5 million (down 5.53% YoY), and the FY2025 annual result was $5.6 million, down 19.25% from the prior year.
• Operating Expenses came in at $1.3 million for Q1 2026 at Biomerica, down from $1.4 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.4 million in Q2 2022 to a low of $1.2 million in Q1 2025.
• The 5-year median for Operating Expenses is $1.7 million (2024), against an average of $1.7 million.
• Across the five-year window, Operating Expenses jumped 38.83% in 2022 and sank 33.6% in 2025, its largest moves.
• Biomerica's Operating Expenses stood at $2.0 million in 2022, then declined by 4.21% to $1.9 million in 2023, then fell by 26.02% to $1.4 million in 2024, then retreated by 0.42% to $1.4 million in 2025, then retreated by 11.94% to $1.3 million in 2026.
• The last three Operating Expenses figures came in at $1.3 million (Q1 2026), $1.4 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.